Correlation Between Twist Bioscience and Aclaris Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Twist Bioscience and Aclaris Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Twist Bioscience and Aclaris Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Twist Bioscience Corp and Aclaris Therapeutics, you can compare the effects of market volatilities on Twist Bioscience and Aclaris Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Twist Bioscience with a short position of Aclaris Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Twist Bioscience and Aclaris Therapeutics.

Diversification Opportunities for Twist Bioscience and Aclaris Therapeutics

-0.19
  Correlation Coefficient

Good diversification

The 3 months correlation between Twist and Aclaris is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Twist Bioscience Corp and Aclaris Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aclaris Therapeutics and Twist Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Twist Bioscience Corp are associated (or correlated) with Aclaris Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aclaris Therapeutics has no effect on the direction of Twist Bioscience i.e., Twist Bioscience and Aclaris Therapeutics go up and down completely randomly.

Pair Corralation between Twist Bioscience and Aclaris Therapeutics

Given the investment horizon of 90 days Twist Bioscience is expected to generate 18.72 times less return on investment than Aclaris Therapeutics. But when comparing it to its historical volatility, Twist Bioscience Corp is 1.86 times less risky than Aclaris Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Aclaris Therapeutics is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  105.00  in Aclaris Therapeutics on August 24, 2024 and sell it today you would earn a total of  327.00  from holding Aclaris Therapeutics or generate 311.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Twist Bioscience Corp  vs.  Aclaris Therapeutics

 Performance 
       Timeline  
Twist Bioscience Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Twist Bioscience Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Twist Bioscience is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Aclaris Therapeutics 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Aclaris Therapeutics are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Aclaris Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Twist Bioscience and Aclaris Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Twist Bioscience and Aclaris Therapeutics

The main advantage of trading using opposite Twist Bioscience and Aclaris Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Twist Bioscience position performs unexpectedly, Aclaris Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclaris Therapeutics will offset losses from the drop in Aclaris Therapeutics' long position.
The idea behind Twist Bioscience Corp and Aclaris Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine